Ciprofloxacin in Respiratory Tract Infections

Faroque Ahmad Khan



Of the quinolone class of antimicrobials, only oral ciprofloxacin is currently approved for respiratory indications. Ciprofloxacin has good tissue penetration and is active against most gram-negative and gram-positive pathogens, including Staplylococcus sp. It is, however, less effective against anaerobic bacteria and Streptococcus pneumoniae. The drug may be useful for managing bacterial exacerbations of COPD and for treating elderly patients with respiratory tract infections, including nosocomial pneumonias. Ciprofloxacin probably alters metabolism of theophylline and some antacids interfere with its absorption and antibacterial activity.


Quinolone; Ciprofloxacin; Respiratory Tract Infection

Full Text:



Islamic Medical Association of North America (IMANA) | JIMA and IMANA on Twitter


Creative Commons License
This work by Work's author(s) is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.